Drug Research
Drug Discovery & Development

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
46-60 of 149 results
Growing Potential: mAb Production With Fibra-Cel
| By Eppendorf
The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.
Drug Research > Drug Discovery & Development > White Papers
DoE Bioprocess Development
| By Eppendorf
Eppendorf DASware is the effective route to design of experiments (DoE) in early-stage bioprocess development. Claudia M Huether-Franken and Sebastian Kleebank explain how the design software applies DoE to DASGIP parallel bioreactor systems.
Drug Research > Drug Discovery & Development > White Papers
Designing Wellness for Fun and Satisfaction: Gummies - Based Nutrition
| By Softigel pbr
The gummy delivery form for vitamins, minerals and supplements is the single-largest source of growth among the supplements category. Vitamin users report preference for gummy/soft chewable products because these offer not only pleasure and a fun experience, but efficacy and convenience. The selection of materials during the design process of the formula is critical for the final product in order to meet the expectations of the consumers, which is to find a healthy product that will give them a delicious reward as well. Based on the design and development process, this paper reviews review in detail the stage of selection of materials and validation as a critical phase to obtain a product that represents quality and stability as well as the specific requirements of the costumers and the consumers.
Drug Research > Drug Discovery & Development > White Papers
A High Quality Formulation Development and Manufacturing Company
| By Alpex Pharma
Our predominant focus is the development of solid dosage forms to deliver drugs directly into the oral cavity in order to potentially improve both the bioavailablity of the drug as well as patient compliance and convenience to it. Alpex Pharma has 28 years of cGMP manufacturing experience and formulation development.
Drug Research > Drug Discovery & Development > White Papers
Best Practices for Streamlining Electronic Implementation of Established COAs; Copyright January 2015
| By ERT
This paper addresses the best practices for building an electronic Clinical Outcome Assessment (eCOA) solution in support of clinical research as it relates to the operational and licensing compliance aspects of administering COAs on electronic platforms.
Drug Research > Drug Discovery & Development > White Papers
Symptoms and Impact of COPD Assessed by an Electronic Diary in Patients with Moderate-to-Severe COPD: Psychometric Results from the SHINE Study; International Journal of COPD; January 2015.
| By ERT
This paper presents the results of psychometric assessment data from a COPD eDiary developed by Novartis to provide a more detailed assessment of symptom frequency and severity and their impact on patients with COPD.
Drug Research > Drug Discovery & Development > White Papers
The Use of Ambulatory Blood Pressure Monitoring in Drug Development; Copyright, January 2015
| By ERT
This white paper delves into the basics of blood pressure, along with the well-documented limitations of standard and digital office blood pressure measurements. It reviews ABPM device functionality, common drug classes where blood pressure monitoring comes into play and compares the advantages and disadvantages of different monitoring options in clinical studies.
Drug Research > Drug Discovery & Development > White Papers
The Use of Continuous ECG Recordings (Holters) in Drug Development; Copyright, December 2014
| By ERT
Continuous 12 lead ECG recorders, often referred to as Holter devices, offer specific advantages to be considered over the standard 12 lead ECGs often collected during clinical trials for cardiac safety. This white paper explores the history of Holters, how sponsors, sites, and patients use these devices, and the benefits of continuous ECG recordings.
Drug Research > Drug Discovery & Development > White Papers
Predictive Value of Baseline electronic Columbia-Suicide Severity Rating Scale (eC-SSRS) Assessments for Identifying Risk of Prospective Reports of Suicidal Behavior During Clinical Research; Innovations in Clinical Neuroscience; November 2014
| By ERT
This meta-analysis examined the ability of baseline eC-SSRS lifetime suicidal ideation and behavior categories to predict prospective reports of suicidal behavior in psychiatric and non-psychiatric research participants. The review of over 74,000 eC-SSRS assessments determined that increasingly more severe lifetime suicidal ideation at baseline was associated with a progressively greater likelihood of prospectively reported suicidal behavior during study participation.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: Bacteria Welcome
| By Eppendorf
BioBLU® f – Single-use vessels that meet microbial demands.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: Extra Versatile
| By Eppendorf
New Brunswick’s BioFlo®/CelliGen® 115 Autoclavable Fermentor and Bioreactor handles a wide variety of cells to meet your every need.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: When Less is More
| By Eppendorf
New Brunswick’s CelliGen® BLU Single-Use Bioreactor System.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: Benchtop Convenience
| By Eppendorf
New Brunswick™ BioFlo® 415 SIP fermentation systems.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: Customizable Control
| By Eppendorf
New Brunswick™ BioFlo® 510 benchtop SIP fermentation systems.
Drug Research > Drug Discovery & Development > White Papers
46-60 of 149 results